Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285)

Publisher： Karger

E-ISSN： 1423-0232|66|2|118-125

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.2, 2004-05, pp. : 118-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 215-218

Karger

Access to resources Recommend Favorite

5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-07 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 297-300

Karger

Access to resources Recommend Favorite

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 427-431

Karger

Access to resources Recommend Favorite